Back to JAGSNPHARM
Clear

Board Meetings for JAGSNPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
JAGSNPHARMJagsonpal Pharmaceuticals Limited23 Oct 2024JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2024 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2024 and Stock split.Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited07 Aug 2024Financial ResultsTo consider and approve the unaudited financial results for the period ended Jun 30, 2024
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited07 Aug 2024JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited20 May 2024JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 20-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend.Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited20 May 2024Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2024 and dividend
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited02 Feb 2024JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited02 Feb 2024Financial ResultsTo consider and approve the financial results for the period ended December 31, 2023
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited03 Nov 2023JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 03-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited03 Nov 2023Financial ResultsTo consider and approve the unaudited financial results for the quarter and half year ended September 30, 2023
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited02 Aug 2023JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited02 Aug 2023Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2023
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited23 May 2023JAGSONPAL PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend.Board Meeting Intimation
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited23 May 2023Financial Results/DividendTo consider and approve the financial results for the period ended March 31, 2023 and dividend
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited08 Feb 2023Financial ResultsTo consider and approve the financial results for the period ended December 31, 2022
PDF
JAGSNPHARMJagsonpal Pharmaceuticals Limited09 Nov 2022Financial resultsJagsonpal Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 09-Nov-2022 to consider financial statements for the period ended September 2022
PDF
Showing page 2 of 8 (110 total items)
PreviousNext